Abpro Holdings, Inc. (ABP)

Revance Therapeutics Revenue

Abpro Holdings had revenue of $183.00K in the twelve months ending March 31, 2025, up 88.66% year-over-year. In the year 2024, Abpro Holdings had annual revenue of $183.00K with 50.00% growth.

• Revenue (ttm): $183.00K
• Revenue Growth: +88.66%
• P/S Ratio: 41.02
• Revenue / Employee: $12,200
• Employees: 15
• Market Cap: 15.01M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	183.00K	61.00K	50.00%
Dec 31, 2023	122.00K	-1.91M	-93.99%
Dec 31, 2022	2.03M	1.55M	322.71%
Dec 31, 2021	480.00K	-1.72M	-78.19%
Dec 31, 2017	2.20M	516.00K	30.62%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.